<DOC>
	<DOCNO>NCT00788463</DOCNO>
	<brief_summary>The purpose study determine intranasal Beclomethasone deliver aerosol spray effective treatment nasal polyp .</brief_summary>
	<brief_title>A Comparison Beclomethasone Aqueous Spray Aerosol Delivery Systems Nasal Polyps</brief_title>
	<detailed_description>Aqueous aerosol delivery intranasal corticosteroid never directly compare previously patient nasal polyp unknown whether one superior . This objective study compare efficacy intranasal beclomethasone two different delivery system , aerosol aqueous spray patient nasal polyp . Primary endpoint difference overall quality life measure Rhinitis Quality Life Questionnaire . The secondary endpoint change Nasal Airflow Resistance measure rhinomanometry .</detailed_description>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>18 year old New diagnosis nasal polyp confirm two physician Intranasal corticosteroid use within 4 week Oral corticosteroid use within 4 week Oral corticosteroid inhalation ( ie treatment asthma COPD ) Budesonide &gt; 400ug daily , Fluticasone &gt; 250ug daily , Beclomethasone &gt; 400ug daily Contraindication intranasal corticosteroid Inability give inform consent Participation another clinical trial Pregnancy ( use effective method contraception ) lactation Cystic fibrosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>administration , intranasal</keyword>
	<keyword>aerosol</keyword>
	<keyword>beclomethasone</keyword>
	<keyword>QVAR</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>nasal polyp</keyword>
	<keyword>rhinomanometry</keyword>
	<keyword>Rhinitis Quality Life Questionnaire</keyword>
	<keyword>Quality Life</keyword>
</DOC>